593 related articles for article (PubMed ID: 17721737)
1. Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea.
Flemming K; Ackermann G
Infection; 2007 Oct; 35(5):356-8. PubMed ID: 17721737
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus.
Boyce JM; Havill NL
Am J Gastroenterol; 2005 Aug; 100(8):1828-34. PubMed ID: 16086721
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea.
Ackermann G; Thomalla S; Ackermann F; Schaumann R; Rodloff AC; Ruf BR
J Med Microbiol; 2005 Feb; 54(Pt 2):149-153. PubMed ID: 15673508
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
Asha NJ; Tompkins D; Wilcox MH
J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.
Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC
Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714
[TBL] [Abstract][Full Text] [Related]
7. [Intestinal flora of patients with suspected antibiotic associated diarrhea (AAD). I. Clostridium perfringens].
Pituch H; Martirosian G; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2000; 52(4):375-82. PubMed ID: 11286179
[TBL] [Abstract][Full Text] [Related]
8. [Yield of detection of Clostridium difficile toxin versus stool culture in the study of nosocomial diarrhea].
Rabasa M; Aguado JM; Lizasoaín M; Pedraza MA; Arribas P; Lumbreras C; Otero JR; Noriega AR
Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):479-81. PubMed ID: 8305554
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.
Martirosian G; Szczesny A; Cohen SH; Silva J
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):153-5. PubMed ID: 15964504
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M
Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
13. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
[TBL] [Abstract][Full Text] [Related]
14. Detection of Clostridium difficile toxin A and B genes from stool samples of Thai diarrheal patients by polymerase chain reaction technique.
Wongwanich S; Rugdeekha S; Pongpech P; Dhiraputra C
J Med Assoc Thai; 2003 Oct; 86(10):970-5. PubMed ID: 14650710
[TBL] [Abstract][Full Text] [Related]
15. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
16. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease.
Debast SB; van Kregten E; Oskam KM; van den Berg T; Van den Berg RJ; Kuijper EJ
Clin Microbiol Infect; 2008 Jun; 14(6):622-4. PubMed ID: 18393996
[TBL] [Abstract][Full Text] [Related]
17. [Clostridium difficile strains not producing Toxin A, but producing Toxin B [toxA(-)tox B(+)]--etiologic agent of antibiotic associated diarrhoea (AAD) in Poland].
Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2002; 54(1):45-53. PubMed ID: 12185683
[TBL] [Abstract][Full Text] [Related]
18. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
19. [Isolation of toxigenic strains of Clostridium difficile and enterotoxin producing Bacteroides fragilis from fecal specimens of patients suspected of antibiotic associated diarrhoea].
Pituch H; Leszczyński P; van Belkum A; Obuch-Woszczatyński P; Rouyan GS; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1999; 51(1-2):59-66. PubMed ID: 10865431
[TBL] [Abstract][Full Text] [Related]
20. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
Chan EL; Seales D; Drum H
Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
